Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 143.26
0.944 %
$ 14.5 B
Market Cap
38.2
P/E
NBIX - CHANGE IN WORKING CAPITAL
Change in Working Capital NBIX - Neurocrine Biosciences, Inc.
28.2 M
LAST VALUE
29.95%
2 YEAR CAGR
78.36%
5 YEAR CAGR
8.83%
10 YEAR CAGR